SD BIOSENSOR, INC Financials SD BioSensor, Inc
Equities
A137310
KR7137310009
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,540 KRW | +0.48% |
|
+4.46% | -7.87% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 57,36,545 | 30,74,925 | 13,99,655 | 12,89,542 | - |
| Enterprise Value (EV) 2 | 4,532 | 1,154 | 1,400 | 1,448 | 1,482 |
| P/E ratio | 5.16 x | 3.46 x | -2.71 x | -27 x | -34.7 x |
| Yield | 2.26% | 6.49% | - | - | - |
| Capitalization / Revenue | 1.96 x | 1.05 x | 2.13 x | 1.82 x | 1.63 x |
| EV / Revenue | 1.55 x | 0.39 x | 2.13 x | 2.05 x | 1.87 x |
| EV / EBITDA | 3.26 x | 0.97 x | - | 21.3 x | 18.5 x |
| EV / FCF | 4.34 x | 1.96 x | - | -36.4 x | -38.2 x |
| FCF Yield | 23.1% | 51% | - | -2.75% | -2.62% |
| Price to Book | 2.58 x | 1.07 x | - | 1.6 x | 1.59 x |
| Nbr of stocks (in thousands) | 1,02,622 | 1,01,988 | 1,22,347 | 1,22,347 | - |
| Reference price 3 | 55,900 | 30,150 | 11,440 | 10,540 | 10,540 |
| Announcement Date | 25/02/22 | 09/03/23 | 28/02/24 | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 2,931 | 2,928 | 655.7 | 707.3 | 793.5 |
| EBITDA 1 | - | 1,389 | 1,187 | - | 68 | 80.2 |
| EBIT 1 | - | 1,370 | 1,147 | -248.1 | -46.8 | -33.3 |
| Operating Margin | - | 46.73% | 39.16% | -37.83% | -6.62% | -4.2% |
| Earnings before Tax (EBT) 1 | - | 1,444 | 1,242 | -438.6 | -64.3 | -50 |
| Net income 1 | 615.6 | 1,066 | 883.4 | -467.7 | -48.7 | -37.9 |
| Net margin | - | 36.36% | 30.17% | -71.33% | -6.89% | -4.78% |
| EPS 2 | 6,583 | 10,824 | 8,721 | -4,219 | -391.0 | -304.0 |
| Free Cash Flow 3 | - | 10,44,892 | 5,88,234 | - | -39,800 | -38,800 |
| FCF margin | - | 35,644.57% | 20,087.21% | - | -5,627.03% | -4,889.73% |
| FCF Conversion (EBITDA) | - | 75,230.03% | 49,537.81% | - | - | - |
| FCF Conversion (Net income) | - | 98,027.29% | 66,585.09% | - | - | - |
| Dividend per Share 2 | - | 1,266 | 1,957 | - | - | - |
| Announcement Date | 14/05/21 | 25/02/22 | 09/03/23 | 28/02/24 | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 526.7 | 443.8 | 1,388 | 795 | 551.2 | 193.8 | 182.4 | 162.6 | 151 | 159.6 |
| EBITDA | - | - | - | - | - | - | - | - | -9.591 | - |
| EBIT 1 | 249.5 | 147.9 | 619.6 | 348.1 | 293.4 | -114.6 | -123.8 | -76.41 | -44.24 | -29.61 |
| Operating Margin | 47.37% | 33.32% | 44.63% | 43.79% | 53.24% | -59.13% | -67.86% | -46.98% | -29.29% | -18.55% |
| Earnings before Tax (EBT) | - | 156 | 648.7 | 466.9 | 487.4 | -361 | - | - | - | - |
| Net income 1 | - | 130.5 | 474.5 | 340 | 421.3 | -352.4 | - | -82.49 | -64.12 | -98.43 |
| Net margin | - | 29.4% | 34.17% | 42.77% | 76.44% | -181.84% | - | -50.72% | -42.45% | -61.67% |
| EPS | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 15/11/21 | 25/02/22 | 12/05/22 | 03/08/22 | 03/11/22 | 09/03/23 | 15/05/23 | 11/08/23 | 13/11/23 | 28/02/24 |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 159 | 193 |
| Net Cash position 1 | - | 1,205 | 1,921 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | 2.334 x | 2.401 x |
| Free Cash Flow 2 | - | 10,44,892 | 5,88,234 | - | -39,800 | -38,800 |
| ROE (net income / shareholders' equity) | - | 72% | 34.2% | -15.6% | -1.8% | -1.4% |
| ROA (Net income/ Total Assets) | - | 47.7% | 29% | - | -1.3% | -1% |
| Assets 1 | - | 2,236 | 3,051 | - | 3,746 | 3,790 |
| Book Value Per Share 3 | - | 21,658 | 28,207 | - | 6,603 | 6,648 |
| Cash Flow per Share | - | 12,554 | 8,788 | - | - | - |
| Capex 1 | - | 190 | 302 | - | 55.5 | 67.5 |
| Capex / Sales | - | 6.48% | 10.31% | - | 7.85% | 8.51% |
| Announcement Date | 14/05/21 | 25/02/22 | 09/03/23 | 28/02/24 | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10,540
KRW
Average target price
10,000
KRW
Spread / Average Target
-5.12%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.87% | 952M | |
| -1.89% | 12.56B | |
| -9.59% | 7.68B | |
| -1.31% | 5.29B | |
| +21.82% | 5.24B | |
| +0.02% | 4.57B | |
| -50.89% | 3.29B | |
| +6.42% | 2.6B | |
| -10.02% | 2.2B | |
| -8.29% | 1.79B |
- Stock Market
- Equities
- A137310 Stock
- Financials SD BioSensor, Inc
